trending Market Intelligence /marketintelligence/en/news-insights/trending/_CmFyE5nKhlUmp7UAT-xzQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

China's YiChang HEC ChangJiang to acquire drug ingredient manufacturer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


China's YiChang HEC ChangJiang to acquire drug ingredient manufacturer

China's YiChang HEC ChangJiang Pharmaceutical Co. Ltd. agreed to acquire HEC Pharmacy Co. Ltd. for 124,700 yuan in cash.

HEC Pharmacy manufactures active pharmaceutical ingredients. YiChang HEC ChangJiang, which manufactures pharmaceutical products, expects the deal to enhance its production.

Shenzhen HEC Industrial Development Co. Ltd. is making the sale through its units HEC Pharm Co. Ltd., which owns 85% of HEC Pharmacy, and Yidu HEC Industrial Development Co. Ltd., which owns the remaining 15%. The units will receive 105,995 yuan and 18,705 yuan, respectively, of the cash consideration within 15 business days of the transaction gaining regulatory approval.

As of Dec. 14, US$1 was equivalent to 6.91 Chinese yuan.